Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Repealing the Job-Killing Health Care Law Act
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 319 -- drug reimportation H.R. 2 -- healthcare reform bill repeal PDUFA reauthorization; Life sciences research tax credit legislation Orphan drug issues
Repealing the Job-Killing Health Care Law Act
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 319 -- drug reimportation PDUFA reauthorization H.R.2632, S.1410 -- Life Sciences Jobs and Investment Act Orphan drugs H.R.2672, S.1423 -- Preserving Access to Orphan Drugs Act of 2011 H.R. 2 -- healthcare reform bill repeal Medicare rebates and reimbursement rates 340B drug discount program H.R.2674 -- 340B Program Improvement Act
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
MERCHANT CUSTOMER EXCHANGE LLC ("MCX") via CONSTANTINE CANNON, LLP
2013 · second_quarter · Q2
Discussion of MCX's mobile payments and offers solution.
Filing targets: HOUSE OF REPRESENTATIVES
MERCHANT CUSTOMER EXCHANGE LLC ("MCX") via CONSTANTINE CANNON, LLP
2012 · fourth_quarter · Q4
Source: Senate LDA
| WHOLE FOODS MARKETS, INC. | 1 | 2009 |
Repealing the Job-Killing Health Care Law Act
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 319 -- drug reimportation PDUFA reauthorization H.R.2632, S.1410 -- Life Sciences Jobs and Investment Act Orphan drugs H.R.2672, S.1423 -- Preserving Access to Orphan Drugs Act of 2011 H.R. 2 -- healthcare reform bill repeal Medicare rebates and reimbursement rates 340B drug discount program H.R.2674 -- 340B Program Improvement Act
Repealing the Job-Killing Health Care Law Act
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 319 -- drug reimportation H.R. 2 -- healthcare reform bill repeal PDUFA reauthorization; Life sciences research tax credit legislation Orphan drug issues
Life Sciences Jobs and Investment Act of 2011
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 319 -- drug reimportation PDUFA reauthorization H.R.2632, S.1410 -- Life Sciences Jobs and Investment Act Orphan drugs H.R.2672, S.1423 -- Preserving Access to Orphan Drugs Act of 2011 H.R. 2 -- healthcare reform bill repeal Medicare rebates and reimbursement rates 340B drug discount program H.R.2674 -- 340B Program Improvement Act
Life Sciences Jobs and Investment Act of 2011
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 319 -- drug reimportation PDUFA reauthorization H.R.2632, S.1410 -- Life Sciences Jobs and Investment Act Orphan drugs H.R.2672, S.1423 -- Preserving Access to Orphan Drugs Act of 2011 H.R. 2 -- healthcare reform bill repeal Medicare rebates and reimbursement rates 340B drug discount program H.R.2674 -- 340B Program Improvement Act
Preserving Access to Orphan Drugs Act of 2011
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 319 -- drug reimportation PDUFA reauthorization H.R.2632, S.1410 -- Life Sciences Jobs and Investment Act Orphan drugs H.R.2672, S.1423 -- Preserving Access to Orphan Drugs Act of 2011 H.R. 2 -- healthcare reform bill repeal Medicare rebates and reimbursement rates 340B drug discount program H.R.2674 -- 340B Program Improvement Act
Preserving Access to Orphan Drugs Act of 2011
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 319 -- drug reimportation PDUFA reauthorization H.R.2632, S.1410 -- Life Sciences Jobs and Investment Act Orphan drugs H.R.2672, S.1423 -- Preserving Access to Orphan Drugs Act of 2011 H.R. 2 -- healthcare reform bill repeal Medicare rebates and reimbursement rates 340B drug discount program H.R.2674 -- 340B Program Improvement Act
340B Program Improvement Act
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 319 -- drug reimportation PDUFA reauthorization H.R.2632, S.1410 -- Life Sciences Jobs and Investment Act Orphan drugs H.R.2672, S.1423 -- Preserving Access to Orphan Drugs Act of 2011 H.R. 2 -- healthcare reform bill repeal Medicare rebates and reimbursement rates 340B drug discount program H.R.2674 -- 340B Program Improvement Act
340B Program Improvement Act
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 319 -- drug reimportation PDUFA reauthorization H.R.2632, S.1410 -- Life Sciences Jobs and Investment Act Orphan drugs H.R.2672, S.1423 -- Preserving Access to Orphan Drugs Act of 2011 H.R. 2 -- healthcare reform bill repeal Medicare rebates and reimbursement rates 340B drug discount program H.R.2674 -- 340B Program Improvement Act
Safe Drug Disposal Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs Anti-counterfeiting legislation concerning drugs (pedigree) PDUFA reauthorization H.R. 4956, modify approval of oxycodone
Safe Drug Disposal Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336, H.R. 5809, S. 3397 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165 - Life sciences research tax credit legislation H.R. 6165 - Life Sciences research tax credit legislation.
Safe Drug Disposal Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections Life sciences research tax credit legislation
Safe Drug Disposal Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165, S. 4018 - Life sciences research tax credit legislation
Patent Reform Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 369, H.R. 1706 -- patent settlements H.R. 1260, S. 515 -- patent reform
Patent Reform Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 369, H.R. 1706 -- patent settlements H.R. 1260, S. 515 -- patent reform
Patent Reform Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 369, H.R. 1706 -- patent settlements H.R. 1260, S. 515 -- patent reform
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections Life sciences research tax credit legislation
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336, H.R. 5809, S. 3397 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165 - Life sciences research tax credit legislation H.R. 6165 - Life Sciences research tax credit legislation.
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165, S. 4018 - Life sciences research tax credit legislation
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs Anti-counterfeiting legislation concerning drugs (pedigree) PDUFA reauthorization H.R. 4956, modify approval of oxycodone
Secure and Responsible Drug Disposal Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs Anti-counterfeiting legislation concerning drugs (pedigree) PDUFA reauthorization H.R. 4956, modify approval of oxycodone
Secure and Responsible Drug Disposal Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165, S. 4018 - Life sciences research tax credit legislation
Secure and Responsible Drug Disposal Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336, H.R. 5809, S. 3397 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165 - Life sciences research tax credit legislation H.R. 6165 - Life Sciences research tax credit legislation.
Secure and Responsible Drug Disposal Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections Life sciences research tax credit legislation
Promoting Innovation and Access to Life-Saving Medicine Act
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections Life sciences research tax credit legislation
Promoting Innovation and Access to Life-Saving Medicine Act
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs Anti-counterfeiting legislation concerning drugs (pedigree) PDUFA reauthorization H.R. 4956, modify approval of oxycodone
Pathway for Biosimilars Act
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections Life sciences research tax credit legislation
Pathway for Biosimilars Act
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs Anti-counterfeiting legislation concerning drugs (pedigree) PDUFA reauthorization H.R. 4956, modify approval of oxycodone
Protecting Consumer Access to Generic Drugs Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 369, H.R. 1706 -- patent settlements H.R. 1260, S. 515 -- patent reform
Protecting Consumer Access to Generic Drugs Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 369, H.R. 1706 - patent settlements.
Protecting Consumer Access to Generic Drugs Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 369, H.R. 1706 -- patent settlements H.R. 1260, S. 515 -- patent reform
Protecting Consumer Access to Generic Drugs Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 369, H.R. 1706 -- patent settlements H.R. 1260, S. 515 -- patent reform
America's Affordable Health Choices Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs Anti-counterfeiting legislation concerning drugs (pedigree) PDUFA reauthorization H.R. 4956, modify approval of oxycodone
America's Affordable Health Choices Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections Life sciences research tax credit legislation
Health Insurance Industry Antitrust Enforcement Act of 2009
Client: INSURANCE SERVICES OFFICE (ISO) · Firm: CONSTANTINE CANNON, LLP
Legislation affecting the insurance industry. Legislation to repeal the McCarran-Ferguson Act, H.R. 3596 and S. 1681. Financial reform legislation, H.R. 4173.
Health Insurance Industry Antitrust Enforcement Act of 2009
Client: INSURANCE SERVICES OFFICE (ISO) · Firm: CONSTANTINE CANNON, LLP
Legislation affecting the insurance industry. Legislation to repeal the McCarran-Ferguson Act, H.R. 3596 and S. 1681.
Stop Oxy Abuse Act of 2010
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs Anti-counterfeiting legislation concerning drugs (pedigree) PDUFA reauthorization H.R. 4956, modify approval of oxycodone
Physician Payment and Therapy Relief Act of 2010
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336, H.R. 5809, S. 3397 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165 - Life sciences research tax credit legislation H.R. 6165 - Life Sciences research tax credit legislation.
Physician Payment and Therapy Relief Act of 2010
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165, S. 4018 - Life sciences research tax credit legislation
Physician Payment and Therapy Relief Act of 2010
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections Life sciences research tax credit legislation
Diesel Emissions Reduction Act of 2010
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336, H.R. 5809, S. 3397 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165 - Life sciences research tax credit legislation H.R. 6165 - Life Sciences research tax credit legislation.
Life Sciences Jobs and Investment Act of 2010
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336, H.R. 5809, S. 3397 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165 - Life sciences research tax credit legislation H.R. 6165 - Life Sciences research tax credit legislation.
Life Sciences Jobs and Investment Act of 2010
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165, S. 4018 - Life sciences research tax credit legislation
Secure and Responsible Drug Disposal Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165, S. 4018 - Life sciences research tax credit legislation
Secure and Responsible Drug Disposal Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336, H.R. 5809, S. 3397 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165 - Life sciences research tax credit legislation H.R. 6165 - Life Sciences research tax credit legislation.
Secure and Responsible Drug Disposal Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections Life sciences research tax credit legislation
Secure and Responsible Drug Disposal Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs Anti-counterfeiting legislation concerning drugs (pedigree) PDUFA reauthorization H.R. 4956, modify approval of oxycodone
Safe Drug Disposal Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs Anti-counterfeiting legislation concerning drugs (pedigree) PDUFA reauthorization H.R. 4956, modify approval of oxycodone
Safe Drug Disposal Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections Life sciences research tax credit legislation
Safe Drug Disposal Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336, H.R. 5809, S. 3397 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165 - Life sciences research tax credit legislation H.R. 6165 - Life Sciences research tax credit legislation.
Safe Drug Disposal Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165, S. 4018 - Life sciences research tax credit legislation
Health Insurance Industry Antitrust Enforcement Act of 2009
Client: INSURANCE SERVICES OFFICE (ISO) · Firm: CONSTANTINE CANNON, LLP
Legislation affecting the insurance industry. Legislation to repeal the McCarran-Ferguson Act, H.R. 3596 and S. 1681.
Health Insurance Industry Antitrust Enforcement Act of 2009
Client: INSURANCE SERVICES OFFICE (ISO) · Firm: CONSTANTINE CANNON, LLP
Legislation affecting the insurance industry. Legislation to repeal the McCarran-Ferguson Act, H.R. 3596 and S. 1681. Financial reform legislation, H.R. 4173.
America's Healthy Future Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs Anti-counterfeiting legislation concerning drugs (pedigree) PDUFA reauthorization H.R. 4956, modify approval of oxycodone
America's Healthy Future Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections Life sciences research tax credit legislation
Physician Payments Sunshine Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections Life sciences research tax credit legislation
Physician Payments Sunshine Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs Anti-counterfeiting legislation concerning drugs (pedigree) PDUFA reauthorization H.R. 4956, modify approval of oxycodone
Secure and Responsible Drug Disposal Act of 2010
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336, H.R. 5809, S. 3397 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165 - Life sciences research tax credit legislation H.R. 6165 - Life Sciences research tax credit legislation.
Preserve Access to Affordable Generics Act
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 369, H.R. 1706 - patent settlements.
Preserve Access to Affordable Generics Act
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 369, H.R. 1706 -- patent settlements H.R. 1260, S. 515 -- patent reform
Preserve Access to Affordable Generics Act
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 369, H.R. 1706 -- patent settlements H.R. 1260, S. 515 -- patent reform
Preserve Access to Affordable Generics Act
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 369, H.R. 1706 -- patent settlements H.R. 1260, S. 515 -- patent reform
Life Sciences Jobs and Investment Act of 2010
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165, S. 4018 - Life sciences research tax credit legislation
Patent Reform Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 369, H.R. 1706 -- patent settlements H.R. 1260, S. 515 -- patent reform
Patent Reform Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 369, H.R. 1706 -- patent settlements H.R. 1260, S. 515 -- patent reform
Patent Reform Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 369, H.R. 1706 -- patent settlements H.R. 1260, S. 515 -- patent reform
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165, S. 4018 - Life sciences research tax credit legislation
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections Life sciences research tax credit legislation
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336, H.R. 5809, S. 3397 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165 - Life sciences research tax credit legislation H.R. 6165 - Life Sciences research tax credit legislation.
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs Anti-counterfeiting legislation concerning drugs (pedigree) PDUFA reauthorization H.R. 4956, modify approval of oxycodone
Promoting Innovation and Access to Life-Saving Medicine Act
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs Anti-counterfeiting legislation concerning drugs (pedigree) PDUFA reauthorization H.R. 4956, modify approval of oxycodone
Promoting Innovation and Access to Life-Saving Medicine Act
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections Life sciences research tax credit legislation
American Middle Class Tax (AMT) Relief Act of 2007
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs Anti-counterfeiting legislation concerning drugs (pedigree) PDUFA reauthorization H.R. 4956, modify approval of oxycodone
American Middle Class Tax (AMT) Relief Act of 2007
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections Life sciences research tax credit legislation
Superfund Polluter Pays Act
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections Life sciences research tax credit legislation
Superfund Polluter Pays Act
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs Anti-counterfeiting legislation concerning drugs (pedigree) PDUFA reauthorization H.R. 4956, modify approval of oxycodone
Overseas Voting Education and Reform, Safeguarding Every American's Vote Act
Client: INSURANCE SERVICES OFFICE (ISO) · Firm: CONSTANTINE CANNON, LLP
Legislation affecting the insurance industry. Legislation to repeal the McCarran-Ferguson Act, H.R. 3596 and S. 1681. Financial reform legislation, H.R. 4173.
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs Anti-counterfeiting legislation concerning drugs (pedigree) PDUFA reauthorization H.R. 4956, modify approval of oxycodone
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections Life sciences research tax credit legislation
Safe Drug Disposal Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation; S. 301 - physicians payments; H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs; H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; Anti-counterfeiting legislation concerning drugs; Health care reform.
Safe Drug Disposal Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation; H.R. 3200 - health care reform; H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs; Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform); Anti-counterfeiting legislation concerning drugs (pedigree); and S. 301 - physicians payments.
Safe Drug Disposal Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs Anti-counterfeiting legislation concerning drugs (pedigree)
Patent Reform Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 515, H.R. 1260 - patent reform S. 369, H.R. 1706 - patent settlements
Patent Reform Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 515, H.R. 1260 - patent reform S. 369, H.R. 1706 - patent settlements
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation anti-counterfeiting legislation concerning drugs S. 301 - physicians payments
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation; H.R. 3200 - health care reform; H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs; Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform); Anti-counterfeiting legislation concerning drugs (pedigree); and S. 301 - physicians payments.
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs Anti-counterfeiting legislation concerning drugs (pedigree)
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation; S. 301 - physicians payments; H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs; H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; Anti-counterfeiting legislation concerning drugs; Health care reform.
Secure and Responsible Drug Disposal Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs Anti-counterfeiting legislation concerning drugs (pedigree)
Secure and Responsible Drug Disposal Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation; H.R. 3200 - health care reform; H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs; Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform); Anti-counterfeiting legislation concerning drugs (pedigree); and S. 301 - physicians payments.
Secure and Responsible Drug Disposal Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation; S. 301 - physicians payments; H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs; H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; Anti-counterfeiting legislation concerning drugs; Health care reform.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs Anti-counterfeiting legislation concerning drugs (pedigree)
Promoting Innovation and Access to Life-Saving Medicine Act
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation; S. 301 - physicians payments; H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs; H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; Anti-counterfeiting legislation concerning drugs; Health care reform.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation; H.R. 3200 - health care reform; H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs; Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform); Anti-counterfeiting legislation concerning drugs (pedigree); and S. 301 - physicians payments.
Pathway for Biosimilars Act
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation; S. 301 - physicians payments; H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs; H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; Anti-counterfeiting legislation concerning drugs; Health care reform.
Pathway for Biosimilars Act
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation; H.R. 3200 - health care reform; H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs; Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform); Anti-counterfeiting legislation concerning drugs (pedigree); and S. 301 - physicians payments.
Pathway for Biosimilars Act
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs Anti-counterfeiting legislation concerning drugs (pedigree)
Protecting Consumer Access to Generic Drugs Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 369, H.R. 1706 - patent settlements.
Protecting Consumer Access to Generic Drugs Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 369, H.R. 1706 -- patent settlements.
Discussion of MCX's mobile payments and offers solution.
Filing targets: Federal Communications Commission (FCC), Federal Deposit Insurance Corporation (FDIC), Federal Reserve System, HOUSE OF REPRESENTATIVES, SENATE
MERCHANT CUSTOMER EXCHANGE LLC ("MCX") via CONSTANTINE CANNON, LLP
2012 · third_quarter · Q3
Discussion of MCX's mobile payments and offers solution.
Filing targets: Federal Reserve System, Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
MERCHANT CUSTOMER EXCHANGE LLC ("MCX") via CONSTANTINE CANNON, LLP
2012 · third_quarter · RR
Discussion of MCX's mobile payments and offers solution.
AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) via CONSTANTINE CANNON, LLP
2011 · fourth_quarter · Q4
S. 319 -- drug reimportation PDUFA reauthorization H.R.2632, S.1410 -- Life Sciences Jobs and Investment Act Orphan drugs H.R.2672, S.1423 -- Preserving Access to Orphan Drugs Act of 2011 H.R. 2 -- healthcare reform bill repeal Medicare rebates and reimbursement rates 340B drug discount program H.R.2674 -- 340B Program Improvement Act
S. 27 -- patent settlements H.R. 1249, S. 23 -- patent reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) via CONSTANTINE CANNON, LLP
2011 · third_quarter · Q3
S. 319 -- drug reimportation PDUFA reauthorization H.R.2632, S.1410 -- Life Sciences Jobs and Investment Act Orphan drugs H.R.2672, S.1423 -- Preserving Access to Orphan Drugs Act of 2011 H.R. 2 -- healthcare reform bill repeal Medicare rebates and reimbursement rates 340B drug discount program H.R.2674 -- 340B Program Improvement Act
S. 27 -- patent settlements H.R. 1249, S. 23 -- patent reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) via CONSTANTINE CANNON, LLP
2011 · second_quarter · Q2
S. 319 -- drug reimportation H.R. 2 -- healthcare reform bill repeal PDUFA reauthorization; Life sciences research tax credit legislation Orphan drug issues
S. 27 -- patent settlements H.R. 1249, S. 23 -- patent reform
RETAIL INDUSTRY LEADERS ASSOCIATION via CONSTANTINE CANNON, LLP
2011 · second_quarter · Q2
Issues relating to payment systems.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RETAIL INDUSTRY LEADERS ASSOCIATION via CONSTANTINE CANNON, LLP
2011 · first_quarter · Q1
Issues relating to payment systems.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) via CONSTANTINE CANNON, LLP
2011 · first_quarter · Q1
S. 27 -- patent settlements H.R. 1249, S. 23 -- patent reform
S. 319 -- drug reimportation H.R. 2 -- healthcare reform bill repeal PDUFA reauthorization; Life sciences research tax credit legislation Orphan drug issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RETAIL INDUSTRY LEADERS ASSOCIATION via CONSTANTINE CANNON, LLP
2010 · fourth_quarter · Q4
Issues relating to payment systems.
Filing targets: SENATE
AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) via CONSTANTINE CANNON, LLP
2010 · fourth_quarter · Q4
S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165, S. 4018 - Life sciences research tax credit legislation
S. 369, H.R. 1706 -- patent settlements H.R. 1260, S. 515 -- patent reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) via CONSTANTINE CANNON, LLP
2010 · third_quarter · Q3
S. 369, H.R. 1706 -- patent settlements H.R. 1260, S. 515 -- patent reform
S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336, H.R. 5809, S. 3397 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165 - Life sciences research tax credit legislation H.R. 6165 - Life Sciences research tax credit legislation.
Filing targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE
INSURANCE SERVICES OFFICE (ISO) via CONSTANTINE CANNON, LLP
2010 · second_quarter · Q2
Legislation affecting the insurance industry. Legislation to repeal the McCarran-Ferguson Act, H.R. 3596 and S. 1681. Financial reform legislation, H.R. 4173.
Filing targets: SENATE
AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) via CONSTANTINE CANNON, LLP
2010 · second_quarter · Q2
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections Life sciences research tax credit legislation
S. 369, H.R. 1706 -- patent settlements H.R. 1260, S. 515 -- patent reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF CORPORATE COUNSEL via CONSTANTINE CANNON, LLP
2010 · first_quarter · Q1
Issues relating to attorney-client privilege.
Issues regarding potential changes in the accounting industry.
Filing targets: HOUSE OF REPRESENTATIVES
INSURANCE SERVICES OFFICE (ISO) via CONSTANTINE CANNON, LLP
2010 · first_quarter · Q1
Legislation affecting the insurance industry. Legislation to repeal the McCarran-Ferguson Act, H.R. 3596 and S. 1681.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) via CONSTANTINE CANNON, LLP
2010 · first_quarter · Q1
S. 369, H.R. 1706 - patent settlements.
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs Anti-counterfeiting legislation concerning drugs (pedigree) PDUFA reauthorization H.R. 4956, modify approval of oxycodone
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INSURANCE SERVICES OFFICE (ISO) via CONSTANTINE CANNON, LLP
2009 · fourth_quarter · Q4
Legislation affecting the insurance industry. Legislation to repeal the McCarran-Ferguson Act, H.R. 3596 and S. 1681.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF CORPORATE COUNSEL via CONSTANTINE CANNON, LLP
2009 · fourth_quarter · Q4
Issues relating to attorney-client privilege.
Filing targets: HOUSE OF REPRESENTATIVES
AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) via CONSTANTINE CANNON, LLP
2009 · fourth_quarter · Q4
S. 369, H.R. 1706 - patent settlements.
H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs Anti-counterfeiting legislation concerning drugs (pedigree)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) via CONSTANTINE CANNON, LLP
2009 · third_quarter · Q3
S. 369, H.R. 1706 -- patent settlements.
S. 525, H.R. 1298 - drug reimportation; H.R. 3200 - health care reform; H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs; Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform); Anti-counterfeiting legislation concerning drugs (pedigree); and S. 301 - physicians payments.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INSURANCE SERVICES OFFICE (ISO) via CONSTANTINE CANNON, LLP
2009 · third_quarter · Q3
Legislation affecting the insurance industry. Legislation to repeal the McCarran-Ferguson Act, H.R. 3596 and S. 1681.
Filing targets: HOUSE OF REPRESENTATIVES
AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) via CONSTANTINE CANNON, LLP
2009 · second_quarter · Q2
S. 515, H.R. 1260 - patent reform S. 369, H.R. 1706 - patent settlements
S. 525, H.R. 1298 - drug reimportation; S. 301 - physicians payments; H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs; H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; Anti-counterfeiting legislation concerning drugs; Health care reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INSURANCE SERVICES OFFICE (ISO) via CONSTANTINE CANNON, LLP
2009 · second_quarter · Q2
Legislation affecting the insurance industry.
Filing targets: HOUSE OF REPRESENTATIVES
ASSOCIATION OF CORPORATE COUNSEL via CONSTANTINE CANNON, LLP
2009 · first_quarter · Q1
Issues relating to attorney-client privilege.
Filing targets: HOUSE OF REPRESENTATIVES
FOOD MARKETING INSTITUTE via CONSTANTINE CANNON, LLP
2009 · first_quarter · Q1
Issues relating to payment systems.
Filing targets: HOUSE OF REPRESENTATIVES
WHOLE FOODS MARKETS, INC. via CONSTANTINE CANNON, LLP
2009 · first_quarter · Q1
Issues affecting merger enforcement policies in industry.
Issues affecting merger enforcement policies in industry.
Filing targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES
AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) via CONSTANTINE CANNON, LLP
2009 · first_quarter · Q1
S. 525, H.R. 1298 - drug reimportation anti-counterfeiting legislation concerning drugs S. 301 - physicians payments
S. 515, H.R. 1260 - patent reform S. 369, H.R. 1706 - patent settlements
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) via CONSTANTINE CANNON, LLP
2008 · fourth_quarter · Q4
Safeguarding American's Pharmaceuticals Act, H.R. 5839 - concerning counterfeit medicines
Safeguarding American's Pharmaceuticals Act, H.R. 5839 - concerning counterfeit medicines
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FOOD MARKETING INSTITUTE via CONSTANTINE CANNON, LLP
2008 · fourth_quarter · Q4
Issues relating to payment systems.
INSURANCE SERVICES OFFICE (ISO) via CONSTANTINE CANNON, LLP
2008 · fourth_quarter · Q4
Legislation affecting the insurance industry.
ASSOCIATION OF CORPORATE COUNSEL via CONSTANTINE CANNON, LLP
2008 · fourth_quarter · Q4
Issues relating to attorney-client privilege.
AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) via CONSTANTINE CANNON, LLP
2008 · third_quarter · Q3
Physician Payments Sunshine Act of 2007, S. 2029 - concerning marketing codes for interactions with healthcare professionals. Safeguarding American's Pharmaceuticals Act, H.R. 5839 - concerning counterfeit medicines.
Physician Payments Sunshine Act of 2007, S. 2029 - concerning marketing codes for interactions with healthcare professionals. Safeguarding American's Pharmaceuticals Act, H.R. 5839 - concerning counterfeit medicines.
AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) via CONSTANTINE CANNON, LLP
2008 · second_quarter · 2A
Physician Payments Sunshine Act of 2007, S. 2029 - concerning marketing codes for interactions with healthcare professionals. Safeguarding American's Pharmaceuticals Act, H.R. 5839 - concerning counterfeit medicines.
Physician Payments Sunshine Act of 2007, S. 2029 - concerning marketing codes for interactions with healthcare professionals. Safeguarding American's Pharmaceuticals Act, H.R. 5839 - concerning counterfeit medicines.
Filing targets: SENATE
ASSOCIATION OF CORPORATE COUNSEL via CONSTANTINE CANNON, LLP
2008 · third_quarter · Q3
Issues relating to attorney-client privilege.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FOOD MARKETING INSTITUTE via CONSTANTINE CANNON, LLP
2008 · third_quarter · Q3
Issues relating to payment systems.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) via CONSTANTINE CANNON, LLP
2008 · second_quarter · 2A
Physician Payments Sunshine Act of 2007, S. 2029 - concerning marketing codes for interactions with healthcare professionals. Safeguarding American's Pharmaceuticals Act, H.R. 5839 - concerning counterfeit medicines.
Physician Payments Sunshine Act of 2007, S. 2029 - concerning marketing codes for interactions with healthcare professionals. Safeguarding American's Pharmaceuticals Act, H.R. 5839 - concerning counterfeit medicines.
Filing targets: SENATE
FOOD MARKETING INSTITUTE via CONSTANTINE CANNON, LLP
2008 · second_quarter · Q2
Issues pertinent and relevant to the retail industry.
Issues relating to payment systems.
Filing targets: Federal Bureau of Investigation (FBI), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) via CONSTANTINE CANNON, LLP
2008 · second_quarter · Q2
Physician Payments Sunshine Act of 2007, S. 2029 - concerning marketing codes for interactions with healthcare professionals. Safeguarding American's Pharmaceuticals Act, H.R. 5839 - concerning counterfeit medicines.
Physician Payments Sunshine Act of 2007, S. 2029 - concerning marketing codes for interactions with healthcare professionals. Safeguarding American's Pharmaceuticals Act, H.R. 5839 - concerning counterfeit medicines.
Filing targets: SENATE
ASSOCIATION OF CORPORATE COUNSEL via CONSTANTINE CANNON, LLP
2008 · second_quarter · Q2
Issues relating to attorney-client privilege.
Filing targets: SENATE
ASSOCIATION OF CORPORATE COUNSEL via CONSTANTINE CANNON, LLP
2008 · first_quarter · Q1
Issues relating to attorney-client privilege.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RETAIL INDUSTRY LEADERS ASSOCIATION via CONSTANTINE CANNON, LLP
2008 · first_quarter · Q1
All issues pertinent and relevant to the retail industry.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FOOD MARKETING INSTITUTE via CONSTANTINE CANNON, LLP
2008 · first_quarter · 1A
Organized retail crime issues affecting retailers.
Issues relating to payment systems.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE, Treasury, Dept of
FOOD MARKETING INSTITUTE via CONSTANTINE CANNON, LLP
2008 · first_quarter · Q1
Issues relating to payment systems.
All issues pertinent and relevant to the retail industry.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE, Treasury, Dept of
AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) via CONSTANTINE CANNON, LLP
2008 · first_quarter · RR
Intellectual property, FDA, Medicare/Medicaid, R&D, and tax issues affecting pharmaceutical companies
Intellectual property, FDA, Medicare/Medicaid, R&D, and tax issues affecting pharmaceutical companies
Intellectual property, FDA, Medicare/Medicaid, R&D, and tax issues affecting pharmaceutical companies
ASSOCIATION OF CORPORATE COUNSEL via CONSTANTINE CANNON, LLP
2007 · year_end · YY
Issues relating to attorney-client privilege.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FOOD MARKETING INSTITUTE via CONSTANTINE CANNON, LLP
2007 · year_end · YY
Issues relating to payment systems.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RETAIL INDUSTRY LEADERS ASSOCIATION via CONSTANTINE CANNON, LLP
2007 · year_end · YY
Organized retail crime issues affecting retailers.
Filing targets: Federal Bureau of Investigation (FBI), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE, White House Office
INSURANCE SERVICES OFFICE (ISO) via CONSTANTINE CANNON, LLP
2007 · year_end · YY
Legislation affecting the insurance industry.
Filing targets: SENATE
RETAIL INDUSTRY LEADERS ASSOCIATION via CONSTANTINE CANNON, LLP
2007 · mid_year · MM
Organized retail crime issues affecting retailers
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INSURANCE SERVICES OFFICE (ISO) via CONSTANTINE CANNON, LLP
2007 · mid_year · MM
Legislation affecting the insurance industry
Filing targets: SENATE
FOOD MARKETING INSTITUTE via CONSTANTINE CANNON, LLP
2007 · mid_year · MM
Issues relating to payment systems.
Filing targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE
ASSOCIATION OF CORPORATE COUNSEL via CONSTANTINE CANNON, LLP
2007 · mid_year · MM
Issues relating to attorney-client privilege
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INSURANCE SERVICES OFFICE (ISO) via CONSTANTINE CANNON, LLP
2007 · mid_year · RR
Legislation affecting the insurance industry
ASSOCIATION OF CORPORATE COUNSEL via CONSTANTINE CANNON, LLP
2006 · year_end · YY
Issues relating to attorney-client privilege
Filing targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE
FOOD MARKETING INSTITUTE via CONSTANTINE CANNON, LLP
2006 · year_end · YY
Issues relating to payment systems.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FOOD MARKETING INSTITUTE via CONSTANTINE CANNON, LLP
2006 · mid_year · MM
Filing targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE
ASSOCIATION OF CORPORATE COUNSEL via CONSTANTINE CANNON, LLP
2006 · mid_year · RR
Intellectual property, FDA, Medicare/Medicaid, R&D, and tax issues affecting pharmaceutical companies
Intellectual property, FDA, Medicare/Medicaid, R&D, and tax issues affecting pharmaceutical companies
Intellectual property, FDA, Medicare/Medicaid, R&D, and tax issues affecting pharmaceutical companies
Intellectual property, FDA, Medicare/Medicaid, R&D, and tax issues affecting pharmaceutical companies